These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 32746710

  • 1. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C, Han J, Wu T, Bachert C, Fokkens W, Hellings P, Hopkins C, Lee S, Mullol J, Lee JT.
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [Abstract] [Full Text] [Related]

  • 2. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA, Senior BA.
    J Otolaryngol Head Neck Surg; 2023 Sep 28; 52(1):64. PubMed ID: 37759322
    [Abstract] [Full Text] [Related]

  • 3. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H.
    Curr Med Res Opin; 2020 Nov 28; 36(11):1897-1911. PubMed ID: 32847417
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
    Bartier S, Béquignon E, Thibaut de Ménonville C, Verillaud B, Evrard D, Léger M, Papon JF, Coste A, Taillé C.
    J Asthma; 2023 Jan 28; 60(1):139-144. PubMed ID: 35073225
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biologics in Chronic Rhinosinusitis: Current and Emerging.
    Boyd JT, Khanwalkar AR.
    Immunol Allergy Clin North Am; 2024 Nov 28; 44(4):657-671. PubMed ID: 39389716
    [Abstract] [Full Text] [Related]

  • 10. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
    Favier V, Daveau C, Carsuzaa F, Fieux M, Vandersteen C, Castillo L, Papon JF, de Gabory L, Saroul N, Verillaud B, Rumeau C, Jankowski R, Michel J, de Bonnecaze G, Lecanu JB, Coste A, Béquignon E, Malard O, Mortuaire G.
    BMJ Open; 2024 May 15; 14(5):e083112. PubMed ID: 38749694
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L, Khan Mbbs Mph AH, Peters Md AT, Bachert Md PhD C, Wagenmann Md M, Heffler Md PhD E, Hopkins BMBCh C, Hellings Md PhD PW, Zhang PhD M, Xing PhD J, Rowe Md P, Jacob-Nara Md Mph DHSc JA.
    Am J Rhinol Allergy; 2022 Nov 15; 36(6):788-795. PubMed ID: 35837739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. EUFOREA consensus on biologics for CRSwNP with or without asthma.
    Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, Canonica GW, Deneyer L, Desrosiers M, Diamant Z, Han J, Heffler E, Hopkins C, Jankowski R, Joos G, Knill A, Lee J, Lee SE, Mariën G, Pugin B, Senior B, Seys SF, Hellings PW.
    Allergy; 2019 Dec 15; 74(12):2312-2319. PubMed ID: 31090937
    [Abstract] [Full Text] [Related]

  • 16. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
    Rivero A, Liang J.
    Ann Otol Rhinol Laryngol; 2017 Nov 15; 126(11):739-747. PubMed ID: 28918644
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.